These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 31796688)
1. The value of routine laboratory screening in the neonatal intensive care unit. Kazmi SH; Caprio M; Boolchandani H; Mally P; Bailey S; Desai P J Neonatal Perinatal Med; 2020; 13(2):247-251. PubMed ID: 31796688 [TBL] [Abstract][Full Text] [Related]
2. Ursodeoxycholic acid versus phenobarbital for cholestasis in the Neonatal Intensive Care Unit. Lewis T; Kuye S; Sherman A BMC Pediatr; 2018 Jun; 18(1):197. PubMed ID: 29925342 [TBL] [Abstract][Full Text] [Related]
4. Natural history of conjugated bilirubin trajectory in neonates following parenteral nutrition cessation. Mangalat N; Bell C; Graves A; Imseis EM BMC Pediatr; 2014 Dec; 14():298. PubMed ID: 25492029 [TBL] [Abstract][Full Text] [Related]
5. Ursodeoxycholic acid therapy for intractable total parenteral nutrition-associated cholestasis in surgical very low birth weight infants. Al-Hathlol K; Al-Madani A; Al-Saif S; Abulaimoun B; Al-Tawil K; El-Demerdash A Singapore Med J; 2006 Feb; 47(2):147-51. PubMed ID: 16435058 [TBL] [Abstract][Full Text] [Related]
6. Cholestasis affects enteral tolerance and prospective weight gain in the NICU. Niccum M; Khan MN; Middleton JP; Vergales BD; Syed S Clin Nutr ESPEN; 2019 Apr; 30():119-125. PubMed ID: 30904211 [TBL] [Abstract][Full Text] [Related]
7. A double-blind randomised controlled trial of fish oil-based versus soy-based lipid preparations in the treatment of infants with parenteral nutrition-associated cholestasis. Lam HS; Tam YH; Poon TC; Cheung HM; Yu X; Chan BP; Lee KH; Lee BS; Ng PC Neonatology; 2014; 105(4):290-6. PubMed ID: 24576844 [TBL] [Abstract][Full Text] [Related]
8. The biochemical and histopathological effects of ursodeoxycholic acid and metronidazole on total parenteral nutrition-associated hepatic dysfunction: an experimental study. Günsar C; Melek M; Karaca I; Sencan A; Mir E; Ortaç R; Canan O Hepatogastroenterology; 2002; 49(44):497-500. PubMed ID: 11995481 [TBL] [Abstract][Full Text] [Related]
10. High rates of mortality and morbidity occur in infants with parenteral nutrition-associated cholestasis. Willis TC; Carter BA; Rogers SP; Hawthorne KM; Hicks PD; Abrams SA JPEN J Parenter Enteral Nutr; 2010; 34(1):32-7. PubMed ID: 19587385 [TBL] [Abstract][Full Text] [Related]
11. Cholestasis in neonatal intensive care unit: incidence, aetiology and management. Tufano M; Nicastro E; Giliberti P; Vegnente A; Raimondi F; Iorio R Acta Paediatr; 2009 Nov; 98(11):1756-61. PubMed ID: 19664101 [TBL] [Abstract][Full Text] [Related]
12. [Non-erythrocyte blood products transfusion in very preterm and extremely preterm infants in Chinese neonatal intensive care units]. Zhao P; Gu XY; Jiang SY; Wang YC; Cao Y; Zhou WH; Lee K; Zhang Q; Wang J; Zhonghua Er Ke Za Zhi; 2022 Feb; 60(2):94-100. PubMed ID: 35090224 [No Abstract] [Full Text] [Related]
13. Vitamin D status among preterm infants with cholestasis and metabolic bone disease. Ukarapong S; Zegarra W; Navarrete C; Seeherunvong T; Berkovitz G Pediatr Res; 2019 Dec; 86(6):725-731. PubMed ID: 31330529 [TBL] [Abstract][Full Text] [Related]
14. Metabolic Bone Disease of Prematurity: Risk Factors and Associated Short-Term Outcomes. Avila-Alvarez A; Urisarri A; Fuentes-Carballal J; Mandiá N; Sucasas-Alonso A; Couce ML Nutrients; 2020 Dec; 12(12):. PubMed ID: 33321828 [TBL] [Abstract][Full Text] [Related]
15. [Cholestasis associated with prolonged parenteral nutrition in neonates: the role of urso-deoxycholic acid]. Garzón L; Ledo A; Cubells E; Sáenz P; Vento M An Pediatr (Barc); 2009 Jun; 70(6):547-52. PubMed ID: 19443280 [TBL] [Abstract][Full Text] [Related]
16. Total parenteral nutrition-associated cholestasis and risk factors in preterm infants. Alkharfy TM; Ba-Abbad R; Hadi A; Sobaih BH; AlFaleh KM Saudi J Gastroenterol; 2014; 20(5):293-6. PubMed ID: 25253364 [TBL] [Abstract][Full Text] [Related]
17. Ursodeoxycholic acid prevention on cholestasis associated with total parenteral nutrition in preterm infants: a randomized trial. Liu SY; Chang LW; Wang J; Xie M; Chen LL; Liu W World J Pediatr; 2022 Feb; 18(2):100-108. PubMed ID: 34988851 [TBL] [Abstract][Full Text] [Related]
18. Ursodeoxycholic acid treatment in preterm infants: a pilot study for the prevention of cholestasis associated with total parenteral nutrition. Arslanoglu S; Moro GE; Tauschel HD; Boehm G J Pediatr Gastroenterol Nutr; 2008 Feb; 46(2):228-31. PubMed ID: 18223390 [TBL] [Abstract][Full Text] [Related]
19. Randomized controlled trial of early parenteral nutrition cycling to prevent cholestasis in very low birth weight infants. Salvador A; Janeczko M; Porat R; Sekhon R; Moewes A; Schutzman D J Pediatr; 2012 Aug; 161(2):229-33.e1. PubMed ID: 22424948 [TBL] [Abstract][Full Text] [Related]
20. Ursodeoxycholic acid versus placebo in women with intrahepatic cholestasis of pregnancy (PITCHES): a randomised controlled trial. Chappell LC; Bell JL; Smith A; Linsell L; Juszczak E; Dixon PH; Chambers J; Hunter R; Dorling J; Williamson C; Thornton JG; Lancet; 2019 Sep; 394(10201):849-860. PubMed ID: 31378395 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]